Background: Early stage breast cancer patients are long-term survivors and finding techniques that may lower acute and late radiotherapy-induced toxicity is crucial. We compared dosimetry of wedged tangential fields (W-TF), tangential field intensity-modulated radiotherapy (TF-IMRT) and multi-beam IMRT (MB-IMRT) in prone and supine positions for whole-breast irradiation (WBI). Methods: MB-IMRT, TF-IMRT and W-TF treatment plans in prone and supine positions were generated for 18 unselected breast cancer patients. The median prescription dose to the optimized planning target volume (PTV optim ) was 50 Gy in 25 fractions. Dose-volume parameters and indices of conformity were calculated for the PTV optim and organs-at-risk.
Background
Conventional radiotherapy (RT) using wedged tangential fields (W-TF) after breast-conserving surgery improves disease control and breast-cancer related survival. However prolonged follow-up showed an increased RT-induced risk of cardiac events and secondary lung and breast cancer in long-term survivors [1] [2] [3] . Therefore strategies for sparing organs-at-risk (OARs), while maintaining an adequate dose coverage of the target are warranted.
In supine position the whole-breast clinical target volume (CTV WBI ) is concave 1) enwrapping the lung and heart at the left side, and 2) medially adjoining the contralateral breast. Therefore parts of the ipsilateral lung, heart, and contralateral breast may receive intermediate to high doses with W-TF.
Intensity-modulated radiotherapy (IMRT) can provide advantages compared to W-TF. In supine position IMRT using a tangential two-beam set-up (TF-IMRT) can improve dose homogeneity; however its ability to reduce high-dose regions to the underlying heart and lung tissue appear to be limited [4, 5] . Supine multi-beam IMRT (MB-IMRT) may overcome those limitations often at cost of low-or intermediate-dose spread over the contralateral breast and ipsilateral thoracic region [6] [7] [8] [9] [10] .
Prone position modifies the target volume by gravity and moves the breast away from the chest wall. Prone W-TF has previously been used for large, pendulous breasts [11] to reduce fibrosis and improve cosmesis [12, 13] . There are a few studies reporting improved dosimetry by prone TF-IMRT [14] [15] [16] , though data on whole-breast MB-IMRT in prone position are lacking. Moreover, all dosimetric studies comparing prone and supine position used only non-multi-beam techniques [16] [17] [18] [19] [20] . We performed the present study to establish the effect of treatment technique (W-TF, TF-IMRT or MB-IMRT) and position (prone or supine) on dose coverage and heart and lung sparing.
Methods
Eighteen unselected early stage breast cancer patients -6 right-sided and 12 left-sided -presenting for wholebreast irradiation (WBI) without nodal irradiation after breast conserving surgery were included in this study. Three-mm thick computer-tomography scans were acquired with an Aquilion scanner (Toshiba Medical Systems, Tokyo, Japan) in all patients in prone and supine position. Patient set-up and delineation of the clinical and planning target volumes for WBI (CTV WBI and PTV WBI , respectively) and OARs in both treatment positions can be found elsewhere [16, 17] . Extension of the PTV WBI outside the skin into the air accounted for respiration-related breast movement or swelling of the breast during treatment. A flash region was created outside the patient's external contour by expanding the PTV WBI with a 10 mm margin followed by subtraction of the patient's total scanned volume. This flash region was subsequently used in the optimization. A planning target volume for optimization (PTV optim ), a structure used during plan optimization, was generated by removing the in-air part and a 7 mm-wide build-up region underneath the skin from the PTV WBI .
The dosimetric comparison was made for 6 MV photon beams of an Elekta SLi18 linear accelerator (Elekta, Crawley, UK) equipped with a standard 1 cm leaf-width multileaf collimator (MLC). A median prescription dose to the PTV optim was 50 Gy in 25 fractions of 2.0 Gy with the objective of ≥95% of the PTV optim receiving >95% of the prescribed dose and minimization of maximum dose, dose heterogeneity and "hot spots". In both positions TF-IMRT used the same gantry angles as W-TF with the collimator set at 0°and the beams shaped around the PTV WBI with the aid of the MLC. Figure 1 shows the 6-beam setup used in the MB-IMRT plans for rightsided breast tumors in supine position (a) and prone position (b). In both positions MB-IMRT used 6 coplanar beams shaped around the PTV WBI and as in TF-IMRT plans field-in-field segments were created avoiding the ipsilateral lung, heart (in case of left-sided breast tumors) and contralateral breast (for lateral beams in supine position, since medial beams did not traverse the contralateral breast).
A forward planning approach was used for the intensity-modulated and W-TF plans. The convolutionsuperposition dose engine of a Pinnacle version 9.0 treatment planning system (Philips Medical Systems, Andover, US) was used for dose computations between optimization cycles of intensity-modulated plans as well Figure 1 Multi-beam set-up in the prone and supine position. A 6-beam set-up used in the multi-beam intensity-modulated radiotherapy (MB-IMRT) plans for right-sided breast tumors in supine (a) and prone position (b). Gantry angles expressed in the Elekta coordinate system. The most inclined medial beam has the gantry angle of a tangential beam set by virtual simulation [21] . The gantry angles are 0°, |α|, |2α|, 180°-0.5|α|, 180°+ 0.5|α|, and 180°+ 1.5|α| for supine MB-IMRT. The lateral gantry angles in prone MB-IMRT are |α|, |α|+/−24°, the medial gantry angles are |β|, |β|+/− 12°.
as for final plans. Monitor units and MLC shapes were optimized using the optimization tools described before [21] . During optimization, two patient geometries were taken into account: 1) dose computation for PTV WBI was performed using a density override (1 g/cm 3 ) to the above-mentioned flash region; 2) dose computation for the PTV WBI without build-up and OARs was performed without density overrides. To be able to compute both dose distributions in parallel, the patient data at the Pinnacle treatment planning system were duplicated: for the first patient dataset the flash region was set waterequivalent, while for the second patient dataset, the flash region remained at the density of the CT data (in essence, air outside the patient outline). To avoid hot spots outside regions of interest, a "matroska" sequence of shell structures [22] was generated outside the PTV WBI , which were taken into account during optimization. Dose computation for these shell structures was performed using the above-mentioned density override in the flash region. Also the dose update mechanism for changes in leaf positions during optimization took both patient geometries into account. This method was used mainly to account for substantial deformations of the breast during the course of treatments. D 2 and D 98 , or the dose exceeding 2% and 98% of the dose-volume histogram (DVH) points, respectively, were used as surrogates for maximum and minimum dose. These were evaluated for the PTV optim , as well as dose homogeneity (1-(D 2 -D 98 /median dose)). For the heart and ipsilateral lung D 2 , mean dose (D mean ), V 5 , V 10 , V 20 and V 25 or the proportion of the volume receiving at least 5 Gy, 10 Gy, 20 Gy and 25Gy, respectively, were extracted from the DVH data. For the contralateral breast D 2 and D mean were evaluated.
The following indices were also calculated for the PTV optim :
Where A is the volume covered by the PTV optim and B is the volume covered by the 95% isodose, i.e., the volume receiving 47.5 Gy or more. The Jaccard index increases with increase in similarity or overlap between the target volume and the 95% isodose and is a measure of dose conformity of the treatment plan.
Where B1 is the volume covered by the 95-107% isodose, i.e. the volume receiving between 47.5 Gy and 53.5 Gy. The dose-coverage index calculates the proportion of the target, in which the treatment-planning objectives for the target are met.
Where B2 is the volume covered by the 95% isodose and lying outside the PTV optim. . It is the fraction of the 95% isodose non-overlapping the target. If the mismatch index is large, large amounts of normal tissues receive 95% of the prescription dose, i.e., 47.5 Gy.
One-way analysis of variance (ANOVA) was used for a pairwise comparison of dose-volume parameters and indices between MB-IMRT, TF-IMRT and W-TF in the 2 treatment positions.
Results
One hundred-and-eight plans were generated. Figure 2 illustrates typical dose distributions obtained with the 3 techniques in prone and supine position.
Dose homogeneity and dose coverage of the target Table 1 provides numerical data on target coverage and target dose distribution obtained with the 3 techniques in the prone and supine position. D 2 is lowered in prone position resulting in improved dose homogeneity since D 98 was similar for both positions. Significance was obtained for prone MB-IMRT versus all supine techniques and a trend (p=0.05) for prone TF-IMRT compared to supine W-TF regarding D 2 ; moreover prone MB-IMRT obtained better (p<0.01) dose homogeneity compared to supine W-TF and MB-IMRT. Intensitymodulated techniques were able to improve dose homogeneity compared to conventional techniques in both positions, though significance (p=0.002) was only gained for prone MB-IMRT versus prone W-TF.
Prone WBI scored better for Jaccard and mismatch indices (Table 1) . Prone MB-IMRT achieved better results than any supine treatment technique (p≤0.03, both indices); followed by prone TF-IMRT versus supine TF-IMRT and W-TF (p≤0.001, both indices). In supine position MB-IMRT (p<0.001) was the best and W-TF (p<0.001) was the worst technique for both indices. Prone IMRT improved significantly (p<0.01) dose coverage index: prone TF-IMRT vs. supine MB-IMRT and prone MB-IMRT vs. supine MB-IMRT and TF-IMRT. Figure 3 illustrates cumulative DVHs of the ipsilateral lung (all patients) and heart (only left-sided patients), numerical data are presented in Table 2 . Sparing (p<0.001) of the ipsilateral lung by radiation dose was always superior in prone. There was little difference in ipsilateral lung dose between the 3 techniques in prone position, although V 10 and V 20 were significantly lower in prone MB-IMRT vs. prone W-TF. In supine position treatment technique did alter lung dose (p<0.05), MB-IMRT achieved the best and W-TF the worst lung avoidance by radiation dose. A remarking feature is the modified (p=0.003) ipsilateral lung volume in both positions. Mean ± standard deviation for ipsilateral lung volume is 1504 ± 401cc for prone position versus 1409 ± 431cc for supine position.
Dose-volume parameters in OARs
Heart dose was lowered with MB-IMRT compared to TF-IMRT (D 2 , D mean , V 5; p=0.07, 0.05 and 0.03, respectively) and W-TF (D 2 , V 5 , p= 0.009 and 0.07, respectively) in supine position. While in prone position the effect of treatment technique on heart dose is less pronounced. Population averages for heart dose metrics were nonsignificantly lowered in prone compared to supine position. Better heart sparing by radiation dose was consistently obtained in prone position for patients with a PTV optim volume >600cc. While for patients with a PTV optim volume <600cc heart dose metrics were comparable (2/5 patients) or worse (3/5 patients) in prone position compared to supine MB-IMRT.
Neither treatment technique, nor set-up significantly changed doses in the contralateral breast, all procedures achieved a maximum dose <5Gy and mean dose <1.5Gy for all patients. 
Discussion
In supine position IMRT techniques obtain a higher Jaccard index, i.e. superior dose conformity, and less mismatch compared to W-TF with MB-IMRT being the superior technique for both indices. Dose conformity, coverage and mismatch are even better for the prone techniques, becoming statistically significant in prone IMRT plans. This is not surprising, since prone position results in a less concave breast volume. Therefore dose to the axillary and shoulder region is substantially reduced and less of the prescription dose can be expected to be out of the target. Our results confirm the reduction of dose inhomogeneity, with IMRT-techniques compared to standard W-TF. Though differences were rather small and non-significant in supine position, which could be explained by the use of non-mixture beam energies. Prone as compared to supine IMRT does improve dose homogeneity and hot spots with the best results in prone MB-IMRT plans. Our results are in agreement with other publications on prone IMRT. Goodman et al. [15] demonstrated a maximum dose in the target exceeding 110% with prone W-TF in 16 of 20 patients as compared to 1 patient with prone IMRT (TF-IMRT). Another study comparing MB-IMRT, TF-IMRT and 3D-CRT treatment plans of 5 patients planned in prone position reported significantly higher dose homogeneity of MB-IMRT plans vs. TF-IMRT (p=0.003) and 3D-CRT plans (p=0.03) [23] . Hardee et al. [14] observed a maximum dose reduction and improved median dose homogeneity in a prone TF-IMRT vs. 3D-CRT patient cohort. Moreover a 9%-decrease of grade 2 dermatitis and a 16%-reduction of grade ≥2 hyperpigmentation were found in the IMRT group. We expect that improved dose homogeneity and hot spots achieved by prone IMRT -either MB-IMRT or TF-IMRT -will yield lower skin toxicity and better cosmesis [4, 5, 24] . Lung irradiation was lowered with the MB-IMRT technique in supine position, though sparing of the ipsilateral lung appeared to be depending more on the treatment position than on the treatment technique. Prone position resulted in a spectacular decrease in lung dose, which is in coherence with other data [16] [17] [18] [19] [20] . The decrease in lung dose in prone position might also be attributed by the 7% increase in ipsilateral lung volume, for which we don't have an explanation. All prone treatment techniques showed similar lung dose metrics.
Left-sided breast cancer patients are at risk of radiation-induced cardiac events [2] , emphasizing the importance of using more sophisticated techniques to lower the heart dose. In supine position, MB-IMRT is able to lower the heart dose compared to the other techniques as shown both in our data and in other publications [7] [8] [9] . In prone position different treatment techniques have less effect on heart dose, especially between IMRT-techniques. Even with MB-IMRT, only the minority of patients (3/12) benefitted from supine position; which is in coherence with other data [18, 20] . Figure 3 Cumulative dose-volume histograms of the ipsilateral lung (a) and heart (b). All patients were included for the ipsilateral lung, while for the heart only left-sided breast cancer patients were evaluated. Abbreviations: W-TF = wedged tangential fields, TF-IMRT = tangential field intensity-modulated radiotherapy, MB-IMRT = multibeam intensity-modulated radiotherapy. Moreover consistent better heart dose metrics were achieved in prone position for patients with a PTV optim volume of >600cc. A limitation of this study is the absence of dose parameters of the left descending coronary artery, since this is likely associated with increased cardiac mortality. The introduction of supine MB-IMRT was not successful because of its complexity, increase in dose to the contralateral breast and higher integral dose [7] [8] [9] . In contrast with these studies we selected beams that avoided the contralateral breast and removed beams that included too much lung tissue. In this way reducing the dose in the ipsilateral lung with MB-IMRT, both in supine and prone position, was not at cost of low-dose spread over the lung or heart as illustrated by the DVHs (Figure 3) . The dose to the contralateral breast was not increased with MB-IMRT either, moreover a maximum dose <5Gy and mean dose <1.5Gy was obtained for all patients.
As a consequence of the reduced ipsilateral lung and heart dose, better dose distribution and dose coverage, prone IMRT is superior to any supine technique for leftsided patients with larger breasts (PTV optim >600cc) and all right-sided patients. While for left-sided patients with smaller breasts individual comparative planning should be made between supine MB-IMRT and prone IMRT in order to choose the best technique for clinical execution. The dosimetric differences between prone TF-IMRT and prone MB-IMRT are rather small. Whether these "small" dosimetric benefits would cause a clinical benefit is unknown. The more complex and time consuming planning procedure and beam delivery of prone MB-IMRT should also be considered.
Conclusions
MB-IMRT is the preferred technique in supine position by providing better coverage indices of the target and sparing of organs-at-risk. However, prone IMRT is superior to any supine technique for right-sided breast cancer patients and left-sided breast cancer patients with larger breasts. The impact of treatment techniques in prone position is less prominent; moreover dosimetric differences between both IMRT-techniques are rather small.
